Company profile for Alvogen

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Alvogen is a privately held next-generation pharmaceuticals company. Its business model ensures competitive advantage through focused in-house capabilities combined with a network of partners for enhanced speed and flexibility. A unique portfolio of high quality and high barrier products fuels our targeted growth strategy. Currently, Alvogen is present in 30 countries around the world with over 200 strategically selected pharm...
Alvogen is a privately held next-generation pharmaceuticals company. Its business model ensures competitive advantage through focused in-house capabilities combined with a network of partners for enhanced speed and flexibility. A unique portfolio of high quality and high barrier products fuels our targeted growth strategy. Currently, Alvogen is present in 30 countries around the world with over 200 strategically selected pharmaceutical projects in development and registration covering key therapeutic areas including biosimilars.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Alvogen US10 Bloomfield AvenuePine BrookNJ 07058 U.S.A.
Telephone
Telephone
1 973 796 3400
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/alvogen-announces-sale-to-lotus-creating-a-leading-international-specialized-generics-platform-302564869.html

PR NEWSWIRE
26 Sep 2025

https://www.prnewswire.com/news-releases/alvogen-announces-sale-to-lotus-creating-a-leading-international-specialized-generics-platform-302564869.html

PR NEWSWIRE
23 Sep 2025

https://www.prnewswire.com/news-releases/alvogen-completes-comprehensive-refinancing-302396066.html

PR NEWSWIRE
07 Mar 2025

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-26-2025-78017.pdf

FDA
26 Feb 2025

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/alvogen-issues-voluntary-nationwide-recall-one-lot-fentanyl-transdermal-system-25-mcgh-due-defective

FDA
31 Jan 2025

https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaq-nrxp-announces-advance-of-5-million-milestone-payment-from-partners-alvogen-inc-and-lotus-pharmaceutical-co-ltd-1975tw-302059100.html

PR NEWSWIRE
11 Feb 2024

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Alvogen and get a quotation

Alvogen is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Furaltadone HCl bulk offered by Alvogen

Find a price of Mesalazine bulk offered by Alvogen

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty